Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent

Journal of Immunology

Volumn 163, Issue 3, 1999, Pages 1178-1187

  Tisch, Roland ^a   Wang, Bo ^a   Serreze, David V ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; EPITOPE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; INTERLEUKIN 4; PEPTIDE; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HELPER CELL; IMMUNOMODULATION; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ANIMALS; AUTOANTIGENS; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; DRUG COMBINATIONS; ENZYME INDUCTION; EPITOPES, T-LYMPHOCYTE; FEMALE; GLUTAMATE DECARBOXYLASE; IMMUNE TOLERANCE; IMMUNIZATION; INJECTIONS, INTRAPERITONEAL; ISLETS OF LANGERHANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; PEPTIDES; TH2 CELLS; TIME FACTORS;

EID: 0033178763     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bach, J. F. 1994. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15:516.
2. Castano, L., and G. S. Eisenbarth. 1990. Type-1 diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 8:647.
3. Tisch, R., and H. O. McDevitt. 1996. Insulin dependent diabetes mellitus. Cell 85:291.
4. Tisch, R., X. D. Yang, S. M. Singer, R. S. Liblau, L. Fugger, and H. O. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in nonobese diabetic mice. Nature 366:72.
5. Kaufman, D. L., M. Clare-Salzler, J. Tian, T. Forsthuber, G. S. Ting, P. Robinson, M. A. Atkinson, E. E. Sercarz, A. J. Tobin, and P. V. Lehmann. 1993. Spontaneous loss of T cell tolerance to glutamic acid decarboxylase in murine insulin dependent diabetes. Nature 366:69.
6. Geng, L., M. Solimena, R. A. Flavell, R. S. Sherwin, and A. C. Hayday. 1998. Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease. Proc. Natl. Acad. Sci. USA 95:10055.
7. Atkinson, M. A., M. A. Bowman, L. Campbell, B. L. Harrow, D. L. Kaufman, and N. K. Maclaren. 1994. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin dependent diabetes. J. Clin. Invest. 94:2125.
8. Baekkeskov, S., H. J. Aanstoot, S. Christgau, A. Reetz, M. Solimena, M. Cascalho, F. Foli, W. Richter-Olsen, and P. de Camilli. 1990. Identification of the 64K autoantigen in insulin dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151.
9. Tian, J., P. V. Lehmann, and D. L. Kaufman. 1997. Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens. J. Exp. Med. 186: 2039.
10. Rabinovitch, A. 1994. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation? Diabetes 43:613.
11. Mueller, R., T. Krahl, and N. Sarvetnick. 1996. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 184:1093.
12. O'Garra, A. 1998. Cytokines induce the development of functionally heterogenous T helper cell subsets. Immunity 8:275.
13. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15: 297.
14. Rapoport, M. J., A. Jaramillo, D. Zipris, A. H. Lazarus, D. V. Senreze, E. H. Leiter, P. Cyopick, J. S. Danska, and T. L. Delovitch. 1993. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178:87.
15. Cameron, M. J., G. A. Arreaza, P. Zucker, S. W. Chensue, R. M. Streiter, S. Chakrabarti, and T. L. Delovitch. 1997. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J. Immunol. 159:4686.
16. Katz, J. D., C. Benoist, and D. Mathis. 1995. T helper subsets in insulin dependent diabetes. Science 268:1185.
17. Pakala, S. V., M. O. Kurrer, and J. D. Katz. 1997. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. Exp. Med. 186:299.
18. Vyse, T., and J. A. Todd. 1996. Genetic analysis of autoimmune disease. Cell 85:311.
19. Tian, J., M. A. Atkinson, M. Clare-Salzler, A. Herschenfeld, T. Forsthuber, P. V. Lehmann, and D. L. Kaufman. 1996. Nasal administration of glutamic acid decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183:1561.
20. Tisch, R., R. S. Liblau, X. D. Yang, P. Liblau, and H. O. McDevitt. 1998. Induction of GAD65-specific regulatory T cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes 47:894.
21. Tian, J., M. Clare-Salzler, A. Herschenfeld, B. Middleton, D. Newman, R. Mueller, S. Arita, C. Evans, M. A. Atkinson, Y. Mullen, N. Sarvetnick, A. J. Tobin, P. V. Lehmann, and D. L. Kaufman. 1996. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat. Med. 2:1348.
22. Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181:1569.
23. Hosken, N. A., K. Shibuya, A. W. Heath, K. M. Murphy, and A. O'Garra. 1995. The effect of antigen dose in a T cell receptor α /β-transgenic model. J. Exp. Med. 182:1579.
24. Kuhn, R., K. Rajewsky, and W. Muller. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254:707.
25. null mice. J. Exp. Med. 184:2049.
26. + T cells in initiation of insulin dependent diabetes mellitus. Eur. J. Immunol. 26: 1762.
27. + Th1 cells induce diabetes in NOD/SCID mice. J. Clin. Invest. 101:68.
28. Forsthuber, T., H. C. Yip, and P. V. Lehmann. 1996. Induction of Th1 and Th2 immunity in neonatal mice. Science 271:1728.
29. Wang, B. A. Gonzalez, P. Hoglund, J. D. Katz, C. Benoist, and D. Mathis. 1998. Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes 47: 1207.
30. Brewer, J. M., M. Conacher, A. Satoskar, H. Bluethmann, and J. Alexander. 1996. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production. Eur. J. Immunol. 26:2062.
31. Geng, L., M. Solimena, R. A. Flavell, R. S. Sherwin, and A. C. Hayday. 1998. Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease. Proc. Natl. Acad. Sci. USA 95:10055.
32. Bridgett, M., M. Cetkovic-Cvrlje, R. O'Rourke, Y. Shi, S. Narayanswami, J. Lambert, V. Ramiya, S. Baekkeskov, E. H. Leiter. 1998. Differential protection in two transgenic lines of NOD/Lt hyperexpressing the autoantigen GAD65 in pancreatic beta cells. Diabetes 47:1848.
33. g7 in nonobese diabetic mice. Immunogenetics 46:29.
34. Zechel, M. A., J. F. Elliott, M. A. Atkinson, and B. Singh. 1998. Characterization of novel T cell epitopes on 65 kDa and 67 kDa glutamic acid decarboxylase relevant in autoimmune responses in NOD mice. J. Autoimmun. 11:83.
35. Burstein, H. J., and A. K. Abbas. 1993. In vivo role of interleukin-4 in T cell tolerance induced by aqueous protein antigen. J. Exp. Med. 177:457.
36. Zhang, X., T. Brunner, L. Carter, R.W. Dutton, P. Rogers, L. Bradley, T. Sato, J. C. Reed, D Green, and S. L. Swain. 1997. Unequal death in T helper 1 (Th)1 and Th2 effectors: Th1, but not Th2 effectors undergo rapid Fas/FasL-mediated apoptosis. J. Exp. Med. 185:1837.